4 citations · 4 across the 1 of their papers we have counts for
1 paper
Donghoon Kim, Jon Andre Ottesen, Ashwin Kumar +5
Identifying amyloid-beta positive patients is crucial for determining eligibility for Alzheimer's disease (AD) clinical trials and new disease-modifying treatments, but currently r…